The House of Representatives yesterday voted 230-183 to pass AHA-supported legislation (H.R. 986) that would rescind the administration’s latest guidance for states seeking a Section 1332 waiver of certain Affordable Care Act requirements. Under Section 1332 of the ACA, states can apply for a waiver of certain requirements but must demonstrate that the proposed waiver would provide access to quality health care that is at least as comprehensive and affordable as without the waiver. The Centers for Medicare & Medicaid Services and Department of the Treasury last fall issued updated guidance and four waiver concepts for states seeking Section 1332 waivers for plan year 2020 and later, which allow states to test a broader array of approaches to coverage, including promoting private plans that may offer less comprehensive coverage. The legislation also would prohibit similar guidance from being proposed in the future. The agencies this month issued a request for information seeking ideas for additional Section 1332 waiver concepts that states could consider.

Headline
The Senate Appropriations Committee Nov. 17 released its version of the fiscal year 2027 appropriations bill for the departments of Labor, Health and Human…
AHA Cyber Intel
On June 2, the Cybersecurity and Infrastructure Security Agency and other federal agencies released a fact sheet on malicious cyber activity targeting U.S.…
Headline
The Senate Finance Committee Sept. 24 held a markup where it advanced the nomination of Chris Klomp for deputy secretary of the Department of Health and Human…
Headline
The deadline to apply for the inaugural AHA Age-Friendly Healthcare Impact Award is Sept. 25. The award, created by the AHA and The John A. Hartford Foundation…
Headline
The National Institutes of Health has launched its Connecting the Community for Maternal Health Challenge: Research Capacity Building in Maternity Care Deserts…
Headline
The 2027 AHA Rural Healthcare Leadership Conference will be held Jan. 31-Feb. 3 in Orlando, Fla. Join fellow rural hospital CEOs, senior executives, clinical…